{"nct_id":"NCT05409066","title":"Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2022-09-20","start_date_type":"ACTUAL","primary_completion_date":"2029-12","primary_completion_date_type":"ESTIMATED","completion_date":"2029-12","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GMAB"]}